OXALIPLATIN HOSPIRA 5 MG/ML

Israel - English - Ministry of Health

Buy It Now

Active ingredient:
OXALIPLATIN 5 MG/ML
Available from:
NOVAPHARMA LTD
ATC code:
L01XA03
Pharmaceutical form:
CONCENTRATE FOR SOLUTION FOR INFUSION
Administration route:
I.V
Manufactured by:
HOSPIRA UK LTD
Therapeutic group:
OXALIPLATIN
Therapeutic indications:
In combination with 5- fluorouracil and folinic acid (FA) oxaliplatin is indicated for: - adjuvant treatment of stage III ( Duke's C) colon cancer after complete resection of primary tumour - the treatment of metastatic colorectal cancer.
Authorization number:
148203343100
Authorization date:
2012-06-01

Similar products

Search alerts related to this product

Share this information